The VIASURE Real Time PCR product portfolio for the diagnosis of infectious diseases in human samples is now expanded with 14 new products for the following families:

1. Respiratory infections:

  • Quick SARS-CoV-2 (Resp. Viruses Quick Lysis + SARS-CoV-2)
  • Aspergillus diferentiation

2. Tropical & Vector-Borne transmission diseases:

  • Monkeypox Virus
  • Toxoplasma gondii

3. Sexual health:

  • Macrolide resistance-associated mutations
  • Neisseria gonorrhoeae ciprofloxacin resistant

4. Immunosuppressed and Meningitis:

  • Mumps, Enterovirus & Parechovirus
  • Cytomegalovirus (cuantitativo)
  • BK Virus (cuantitativo)

5. Antimicrobial resistance and sepsis:

  • Enteroccoccus faecalis + Enterococcus faecium
  • CTX, TEM, SHV & mcr
  • Enterobacter, A. baumannii & E. coli
  • P. aeruginosa, K. pneumoniae & P. mirabilis

6. VIASURE RNA Viral Particles:

  • VIASURE Viral SARS-CoV-2 Delta (B.1.617.2) Positive Control Kit

With more than 128 available references, all VIASURE kits are presented in lyophilized format, allowing transport and storage at room temperature, without the need for special shipping conditions. Available in different formats, they are compatible with the main open system thermal cyclers on the market.

VIASURE Real Time PCR Detection Kits are included in the VIASURE Complete Solution, a combination of tools and reagents to perform an optimal workflow in the molecular diagnostic laboratory.